|
BIOJECT PRESIDENT AND CEO TO PRESENT AT THE ACUMEN BIOFIN
RODMAN & RENSHAW 9TH ANNUAL
HEALTHCARE CONFERENCE
PORTLAND, OR, November 5, 2007 – Bioject Medical Technologies
Inc. (Nasdaq: BJCT), a leading developer of
needle-free injection therapy systems, today announced that Mr. Ralph
Makar, President and CEO, will present at the Acumen BioFin Rodman &
Renshaw 9th
Annual Healthcare Conference, being held November 5-7, 2007. The
presentation will be held Wednesday, November 7, 2007 at 11:30 am (ET)
at the New York Palace Hotel in New York City.
The presentation will
be webcast live at
http://www.wsw.com/webcast/rrshq12/bjct. An archived replay
will be available at
www.bioject.com for 90 days.
Bioject Medical Technologies Inc., based in Portland, Oregon, is
an innovative developer and manufacturer of needle-free injection
therapy systems (NFITS). NFITS provide an empowering technology
and works by forcing medication at high speed through a tiny orifice
held against the skin. This creates a fine stream of high-pressure
fluid penetrating the skin and depositing medication in the tissue
beneath. The Company is focused on developing mutually beneficial
agreements with leading pharmaceutical, biotechnology, and veterinary
companies.
For more information on Bioject, visit
www.bioject.com.
|
